Beta Bionics (BBNX) vs CeriBell (CBLL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CeriBell (CBLL) has outperformed Beta Bionics (BBNX) over the past year, gaining 99.0% versus a loss of 18.4%. Beta Bionics is the larger company by market cap ($975.3 million vs $901.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | CBLL |
|---|---|---|
| Share price | $18.08 | $23.48 |
| Market cap | $975.35M | $901.12M |
| 1-day change | -2.95% | -3.53% |
| YTD return | -40.66% | +7.07% |
| 1-year return | -18.37% | +98.98% |
| EPS (TTM) | $-1.64 | $-1.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.71 | $25.63 |
| 52-week low | $8.80 | $10.85 |
| Distance from 52-week high | -44.73% | -8.38% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +31.64% | +21.68% |
| Average volume | 1.29M | 369.87K |
| Shares outstanding | 53.95M | 38.38M |
| Employees | 420 | 327 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBLL has outperformed BBNX by 117.4 percentage points over the past year.
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Healthcare · Medical Devices · 420 employees
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Healthcare · Medical Devices · 327 employees
BBNX vs CBLL FAQ
Which is bigger, Beta Bionics or CeriBell?
Beta Bionics (BBNX) is larger, with a market capitalization of $975.35M compared with $901.12M for CeriBell (CBLL).
Which stock has performed better over the past year, BBNX or CBLL?
CBLL returned +98.98% over the past 12 months, compared with -18.37% for BBNX (price return, excluding dividends). Past performance does not predict future results.
Are Beta Bionics and CeriBell in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.